Figure 2. Identification of DEGS related with IGF2PB2 in AD. (A, B) DEGs between AD patients and normal people in GSE33000. (C, E) DEGs between IGF2PB2 high and low group in AD patients in GSE33000. (D) The top25 increased differentially expressed genes and the top25 decreased differentially expressed genes between IGF2PB2 high and low group in AD patients in GSE33000. (F, G) Expression status of systemic inflammation biomarkers and AD pathological markers in IGF2BP2_high and IGF2BP2_low subgroups of AD patients in GSE33000 (F) and GSE48350/5281 (G) datasets.